IUIS FRONTIERS, WEBINAR SERIES ON COVID-19, LOS DÍAS 6 y 13 DE JULIO 2020

 

Logo IUIS y FRONTIERS WEBINAR 2

 

Dear Colleagues and Friends,
 
Join the next IUIS-Frontiers live webinars on COVID-19 with Hans-Martin Jäck on July 6, and Adrian Hayday on July 13! IUIS and Frontiers have collaborated on a series of weekly, expert commentaries and scientific webinars to accelerate the development of novel diagnostics, therapeutics, and vaccines. You can watch the previous webinars on-demand at iuis.org/webinars. Get insights from Rino Rappuoli, Giuseppe Ippolito, Eleanor Fish, Rachel Humphrey, Andreas Radbruch, Mihai Netea, Sharon Lewin, Katherine Kedzierska, Donna Farber, Lisa Ng, Eric Vivier and Salim Karim! We look forward to seeing you at our next live webinars!

 

Prevention and Therapy of COVID-19 with Monoclonal Antibodies

Date: July 06, 2020
Time: 16:00 (CEST)

 

 

Hans Martin Jack SMI

 

Hans-Martin Jäck summarizes the COVID-19 pandemic and CoV-2-host cell interactions. He introduces the concept of passive immunisation and active vaccination to prevent and protect from COVID-19, and he provides an overview of the current clinical serum and vaccine trials, finishing the webinar with a review on the production of human CoV-2 neutralising antibodies in transgenic mice with an entirely human antibody repertoire.

 

 

Tim Sparwasser SMI

 

The webinar will be moderated by Tim Sparwasser, Professor and Director of the Institute of Medical Microbiology and Hygiene (IMMH) of the University Medical Center (UMC) of the Johannes Gutenberg-University, Mainz.

 

REGISTER HERE: WEBINAR PREVENTION AND THERAPY OF COVID-19 WITH MONOCLONAL ANTIBODIES

 

 

https://www.bigmarker.com/iuis/Prevention-and-Therapy-of-COVID-19-with-monoclonal-antibodies

 

 

Seeking correlates of protection and correlates of pathology in COVID-19 patients Date: July 13, 2020
Time: 15:00 (CEST)

Professor Adrian Hayday SMI

In this webinar, Professor Adrian Hayday will share with us, an overview of a completed deep immunophenotyping of 100 patients and controls, with approximately 200,000 data points.

Professor Adrian Hayday began studying immunology in 1982 at MIT, where he and his colleagues first described the wholly unanticipated T-cell receptor gamma chain genes. Establishing that γδ T-cells are distinct from conventional T-cells, Professor Hayday and his colleagues demonstrated that γδ T-cells generate rapid responses to tissue dysregulation to monitor tissue integrity, rather than showing highly specific responses to pathogens, as is the case for conventional T and B cells. Over the course of his career, Professor Hayday has authored over 200 papers, the majority of which are original research contributions. He has received many awards, including the William Clyde deVane Medal, Yale College’s highest honour for scholarship and teaching, an honorary fellowship from King’s College London, and the King’s College Business Award. He was elected to lead the British Society of Immunology (2005-09), and is an elected fellow of the Academy of Medical Sciences and of the Royal Society.

He is currently a Professor of Immunobiology at King’s College London, a Clinical Academic Group leader at King’s Health Partners, and Group Leader at the Francis Crick Institute where he is an Assistant Research Director. 

 

REGISTER HERE: WEBINAR SEEKING CORRELATES OF PROTECTION AND CORRELATES OF PATHOLOGY IN COVID-19 PATIENTS

https://www.bigmarker.com/iuis/Seeking-correlates-of-protection-and-correlates-of-pathology-in-Covid